Kirr Marbach & Co’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9M Buy
116,069
+2,255
+2% +$132K 2.01% 20
2026
Q1
$4.35M Buy
113,814
+13,396
+13% +$424K 0.79% 38
2025
Q4
$2.19M Buy
100,418
+3,569
+4% +$74.1K 0.42% 42
2025
Q3
$2.08M Buy
96,849
+102
+0.1% +$2.29K 0.38% 40
2025
Q2
$2.48M Sell
96,747
-50
-0.1% -$1.46K 0.49% 40
2025
Q1
$3.54M Buy
96,797
+4,386
+5% +$151K 0.82% 35
2024
Q4
$2.83M Sell
92,411
-3,880
-4% -$129K 0.61% 38
2024
Q3
$3.63M Sell
96,291
-484
-0.5% -$18.7K 0.81% 33
2024
Q2
$3.83M Sell
96,775
-45
-0% -$1.46K 0.92% 30
2024
Q1
$3.25M Sell
96,820
-1,165
-1% -$39.2K 0.78% 32
2023
Q4
$3.26M Buy
97,985
+34,425
+54% +$1.11M 0.86% 33
2023
Q3
$1.99M Sell
63,560
-61
-0.1% -$1.92K 0.57% 39
2023
Q2
$2.02M Sell
63,621
-666
-1% -$21.5K 0.56% 40
2023
Q1
$2.12M Buy
64,287
+10,263
+19% +$336K 0.66% 38
2022
Q4
$1.74M Sell
54,024
-9,663
-15% -$329K 0.54% 41
2022
Q3
$2.27M Sell
63,687
-52
-0.1% -$2.16K 0.77% 39
2022
Q2
$2.62M Buy
63,739
+2,017
+3% +$98K 0.82% 40
2022
Q1
$3.57M Buy
61,722
+3,353
+6% +$183K 0.96% 40
2021
Q4
$3.43M Buy
58,369
+2,274
+4% +$138K 0.91% 37
2021
Q3
$3.4M Buy
+56,095
New +$3.29M 1% 36

Other funds holding ATEX

Kirr Marbach & Co's ATEX Position: Q2 2026 in Review

Kirr Marbach & Co increased its Anterix (ATEX) stake by 2% in Q2 2026, buying an estimated $132K and bringing the position to 116,069 shares worth $11.9M. The position accounts for 2.01% of the portfolio, ranked #20.

Kirr Marbach & Co first reported a position in ATEX in Q3 2021 and has held it in 20 quarters since. 30 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Kirr Marbach & Co held 116,069 shares of Anterix worth $11.9M as of Q2 2026.
  • Kirr Marbach & Co bought 2,255 Anterix shares in Q2 2026, an estimated $132K.
  • Anterix made up 2.01% of Kirr Marbach & Co's portfolio in Q2 2026, its #20 holding.
  • Kirr Marbach & Co first reported a position in Anterix in Q3 2021 and has held it in 20 quarters since.
  • 30 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Kirr Marbach & Co's 13F filing for Q2 2026, filed 14 Jul 2026.